, epidemiological and clinical characteristics of patients with COVID-19 are being reported worldwide. A recent study of 191 Chinese patients reported a median viral shedding duration of 20.0 days (IQR 17.0-24.0) in survivors. However, SARS-CoV-2 was detectable until death in nonsurvivors. Moreover, 37 days were reported to be the longest observed duration of viral shedding in survivors. 1 We report the case of a 25 years old woman, working as a resident at the dental clinic of Brest University Hospital, who developed the symptoms of COVID-19 and was tested positive for SARS-CoV-2 RNA twice during 53 days. 2 | METHODS A summary of patient's history, family history, environment, background, clinical examination, biological data, diagnosis, and treatments of the clinical case is provided in Table 1. 3 | RESULTS On 15 March 2020, this young lady presented with the first phase of COVID-19 symptoms, that is, digestive disorders, diarrhea, rhinitis, rheum, buccal aphthous, dry cough, and a 38°C fever. She was previously in good health, non-smoker, without any medication, or known risk factor for COVID-19. She only reported a history of psoriasis of the hand, elbow, and scalp once a year in the past 10 years. Given her healthcare provider status and her mild symptoms, after a first positive SARS-CoV-2 RNA PCR on March 18, she was placed in quarantine at her home. This symptomatic period was associated with appearance of chills, fever (38°C), high fatigue, and ageusia. In addition, she presented with a worsening (upon ante flexion) headache, localized at the forehead and the temporal region. She also presented with body aches especially in the cervical region, the upper back, and the legs during the first week. Additionally, cutaneous manifestations (pruritic lesions) covered all her limbs with approximately 10 × 2 mm of red